Literature DB >> 32631827

CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant Enterobacteriaceae.

Mingju Hao1, Yuzhang He2,3, Haifang Zhang4, Xiao-Ping Liao2,3, Ya-Hong Liu2,3,5, Jian Sun2,3, Hong Du4, Barry N Kreiswirth6, Liang Chen7,8.   

Abstract

Combating plasmid-mediated carbapenem resistance is essential to control and prevent the dissemination of carbapenem-resistant Enterobacteriaceae (CRE). Here, we conducted a proof-of-concept study to demonstrate that CRISPR-Cas9-mediated resistance gene and plasmid curing can effectively resensitize CRE to carbapenems. A novel CRISPR-Cas9-mediated plasmid-curing system (pCasCure) was developed and electrotransferred into various clinical CRE isolates. The results showed that pCasCure can effectively cure bla KPC, bla NDM, and bla OXA-48 in various Enterobacteriaceae species of Klebsiella pneumoniae, Escherichia coli, Enterobacter hormaechei, Enterobacter xiangfangensis, and Serratia marcescens clinical isolates, with a >94% curing efficiency. In addition, we also demonstrated that pCasCure can efficiently eliminate several epidemic carbapenem-resistant plasmids, including the bla KPC-harboring IncFIIK-pKpQIL and IncN pKp58_N plasmids, the bla OXA-48-harboring pOXA-48-like plasmid, and the bla NDM-harboring IncX3 plasmid, by targeting their replication and partitioning (parA in pKpQIL) genes. However, curing the bla OXA-48 gene failed to eliminate its corresponding pOXA-48-like plasmid in clinical K. pneumoniae isolate 49210, while further next-generation sequencing revealed that it was due to IS1R-mediated recombination outside the CRISPR-Cas9 cleavage site resulting in bla OXA-48 truncation and, therefore, escaped plasmid curing. Nevertheless, the curing of carbapenemase genes or plasmids, including the truncation of bla OXA-48 in 49210, successfully restore their susceptibility to carbapenems, with a >8-fold reduction of MIC values in all tested isolates. Taken together, our study confirmed the concept of using CRISPR-Cas9-mediated carbapenemase gene and plasmid curing to resensitize CRE to carbapenems. Further work is needed to integrate pCasCure in an optimal delivery system to make it applicable for clinical intervention.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  CRISPR-Cas; antimicrobial resistance; carbapenem-resistant Enterobacteriaceae; plasmid

Mesh:

Substances:

Year:  2020        PMID: 32631827      PMCID: PMC7449206          DOI: 10.1128/AAC.00843-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli.

Authors:  Haisi Dong; Hua Xiang; Dan Mu; Dacheng Wang; Tiedong Wang
Journal:  Int J Antimicrob Agents       Date:  2018-09-26       Impact factor: 5.283

2.  Eliminating mcr-1-harbouring plasmids in clinical isolates using the CRISPR/Cas9 system.

Authors:  Pengxia Wang; Dongmei He; Baiyuan Li; Yunxue Guo; Weiquan Wang; Xiongjian Luo; Xuanyu Zhao; Xiaoxue Wang
Journal:  J Antimicrob Chemother       Date:  2019-09-01       Impact factor: 5.790

3.  Comparative genomic analysis of KPC-encoding pKpQIL-like plasmids and their distribution in New Jersey and New York Hospitals.

Authors:  Liang Chen; Kalyan D Chavda; Roberto G Melano; Michael R Jacobs; Brian Koll; Tao Hong; Albert D Rojtman; Michael H Levi; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

4.  Genomic Characterization of Two KPC-Producing Klebsiella Isolates Collected in 1997 in New York City.

Authors:  Brandon Eilertson; Liang Chen; Kalyan D Chavda; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 5.  The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2014-09       Impact factor: 8.067

6.  progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement.

Authors:  Aaron E Darling; Bob Mau; Nicole T Perna
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

7.  Molecular Diversity and Plasmid Analysis of KPC-Producing Escherichia coli.

Authors:  Kalyan D Chavda; Liang Chen; Michael R Jacobs; Robert A Bonomo; Barry N Kreiswirth
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

8.  Horizontal Transfer of Carbapenemase-Encoding Plasmids and Comparison with Hospital Epidemiology Data.

Authors:  C A Hardiman; R A Weingarten; S Conlan; P Khil; J P Dekker; A J Mathers; A E Sheppard; J A Segre; K M Frank
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

9.  Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data.

Authors:  Matthew Kearse; Richard Moir; Amy Wilson; Steven Stones-Havas; Matthew Cheung; Shane Sturrock; Simon Buxton; Alex Cooper; Sidney Markowitz; Chris Duran; Tobias Thierer; Bruce Ashton; Peter Meintjes; Alexei Drummond
Journal:  Bioinformatics       Date:  2012-04-27       Impact factor: 6.937

10.  Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.

Authors:  Kalyan D Chavda; Liang Chen; Derrick E Fouts; Granger Sutton; Lauren Brinkac; Stephen G Jenkins; Robert A Bonomo; Mark D Adams; Barry N Kreiswirth
Journal:  MBio       Date:  2016-12-13       Impact factor: 7.867

View more
  15 in total

1.  Multidrug-Resistant Gram-Negative Bacteria in Burn Patients.

Authors:  Laura Ruegsegger; Jamie Xiao; Arash Naziripour; Trey Kanumuambidi; Dylan Brown; Felicia Williams; Steven H Marshall; Susan D Rudin; Kelly Yen; Tingyu Chu; Liang Chen; Emanuele Sozzi; Luther Bartelt; Barry Kreiswirth; Robert A Bonomo; David van Duin
Journal:  Antimicrob Agents Chemother       Date:  2022-09-06       Impact factor: 5.938

Review 2.  Inherent and Composite Hydrogels as Promising Materials to Limit Antimicrobial Resistance.

Authors:  Rahela Carpa; Alexei Remizovschi; Carla Andreea Culda; Anca Livia Butiuc-Keul
Journal:  Gels       Date:  2022-01-20

3.  The Role of the Two-Component QseBC Signaling System in Biofilm Formation and Virulence of Hypervirulent Klebsiella pneumoniae ATCC43816.

Authors:  Jingnan Lv; Jie Zhu; Ting Wang; Xiaofang Xie; Tao Wang; Zhichen Zhu; Liang Chen; Fengyun Zhong; Hong Du
Journal:  Front Microbiol       Date:  2022-04-06       Impact factor: 6.064

Review 4.  Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections.

Authors:  Yuye Wu; Dheerendranath Battalapalli; Mohammed J Hakeem; Venkatarao Selamneni; Pengfei Zhang; Mohamed S Draz; Zhi Ruan
Journal:  J Nanobiotechnology       Date:  2021-12-04       Impact factor: 10.435

Review 5.  What happened to microbiological diagnosis in 2020 beyond COVID-19?

Authors:  E Cercenado
Journal:  Rev Esp Quimioter       Date:  2021-09-30       Impact factor: 1.553

Review 6.  Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles.

Authors:  Fen Wan; Mohamed S Draz; Mengjie Gu; Wei Yu; Zhi Ruan; Qixia Luo
Journal:  Pharmaceutics       Date:  2021-03-08       Impact factor: 6.321

7.  Detection of a New Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Klebsiella pneumoniae Strain at a German University Hospital.

Authors:  Julian Schwanbeck; Wolfgang Bohne; Ufuk Hasdemir; Uwe Groß; Yvonne Pfeifer; Boyke Bunk; Thomas Riedel; Cathrin Spröer; Jörg Overmann; Hagen Frickmann; Andreas E Zautner
Journal:  Microorganisms       Date:  2021-03-31

8.  Solar photon-Fenton process eliminates free plasmid DNA harboring antimicrobial resistance genes from wastewater.

Authors:  Pâmela B Vilela; Alessandra S Martins; Maria Clara V M Starling; Felipe A R de Souza; Giovana F F Pires; Ananda P Aguilar; Maria Eduarda A Pinto; Tiago A O Mendes; Camila C de Amorim
Journal:  J Environ Manage       Date:  2021-02-19       Impact factor: 6.789

Review 9.  CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.

Authors:  Manuel González de Aledo; Mónica González-Bardanca; Lucía Blasco; Olga Pacios; Inés Bleriot; Laura Fernández-García; Melisa Fernández-Quejo; María López; Germán Bou; María Tomás
Journal:  Antibiotics (Basel)       Date:  2021-06-22

Review 10.  Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Elena-Georgiana Dobre; Ilda Czobor Barbu; Roxana Elena Cristian; Marcela Popa; Sang Hee Lee; Carmen Limban; Ilinca Margareta Vlad; Mariana Carmen Chifiriuc
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.